Developments in the diagnostic mycology laboratory
Glenn D. Roberts(Mayo Clinic), William G. Merz(University of California San Diego), Michael A. Pfaller(University of Iowa), E. Guého(Institut Pasteur), Thomas R. Rogers(Scripps Research Institute), C De Vroey(Instituut voor Tropische Geneeskunde)
Cited by 7
Related Papers
Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
|New England Journal of Medicine|1991|947
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
|Clinical Infectious Diseases|1997|863
Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012
|Journal of Clinical Microbiology|2012|485
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464